Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Follow-Up Questions
Quel est le ratio P/E de Cencora Inc (COR) ?
Le ratio P/E de Cencora Inc est de 41.7132
Qui est le CEO de Cencora Inc ?
Dr. Robert Mauch est le President de Cencora Inc, il a rejoint l'entreprise depuis 2015.
Quelle est la performance du prix de l'action COR ?
Le prix actuel de COR est de $326.57, il a increased de 0.58% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Cencora Inc ?
Cencora Inc appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de Cencora Inc ?
La capitalisation boursière actuelle de Cencora Inc est de $63.3B
Est-ce que Cencora Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 17 analystes ont établi des notations d'analystes pour Cencora Inc, y compris 5 achat fort, 11 achat, 6 maintien, 0 vente et 5 vente forte
